Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by Schmidon Jan 11, 2022 11:56am

118 Views

Post# 34303922

Take the time to report bashing

The only way Stockhouse will improve is if people take the time to report spam and bashing. This is another perfect example of posters telling outright lies about a company to lower the price for them to buy. Kiss my azz Canacrap, I used to stand up for you but you've degenerated into a bane to all retail investors with your tactics.

<< Previous

Bullboard Posts

Next >>

Rock Tech notches official permit for German lithium refinery